| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2011 | US8012958 Modulate gene expression of gamma-aminobutyric acid receptors ; antidepressants; psychological disorders; obsessive compulsive disorders ; eating disorders |
| 09/06/2011 | US8012957 Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators |
| 09/06/2011 | US8012956 Tropane compounds |
| 09/06/2011 | US8012955 N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| 09/06/2011 | US8012954 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |
| 09/06/2011 | US8012953 Macrocyclic beta-secretase inhibitors |
| 09/06/2011 | US8012952 Cationic 17 α-substituted-estradiol derivatives useful as anti-cancer agent |
| 09/06/2011 | US8012951 7-N-substituted phenyl tetracycline compounds |
| 09/06/2011 | US8012950 Using tartrate-resistant acid phosphatase activity as diagnostic indicator of degenerative ligament disease; bioassay |
| 09/06/2011 | US8012949 Pyridinium-1-yl, quinolinium-1-yl, and related compounds; parasitic infections, for example against trypanosomes; inhibiting the enzyme farnesyl diphosphate synthase |
| 09/06/2011 | US8012948 Fas/FasL or other death receptor targeted methods and compositions for killing tumor cells |
| 09/06/2011 | US8012947 Methods and compositions for promoting wound healing |
| 09/06/2011 | US8012944 Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent |
| 09/06/2011 | US8012943 Antibacterial agents |
| 09/06/2011 | US8012942 Carba-nucleoside analogs for antiviral treatment |
| 09/06/2011 | US8012941 Carba-nucleoside analogs for antiviral treatment |
| 09/06/2011 | US8012940 Utilization of anti-neuropathic pain effect of D-allose and D-psicose |
| 09/06/2011 | US8012926 Amino acid composition and supplementary liquid containing the same |
| 09/06/2011 | US8012924 Amino acid composition and supplementary liquid containing the same |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012711 Methods of screening for compounds that reduce microbial resistance to fluoroquinolones |
| 09/06/2011 | US8012681 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody |
| 09/06/2011 | US8012514 Chewing gum; a softening agent or an emulsifying agent blended with Magnolia Bark Extract |
| 09/06/2011 | US8012504 Sustained release portion of unit dose containing guaifenesin, dextromethorphan and a release-delaying matrix contains a hydrophilic polymer and a water insoluble polymer, immediate release portion containing guaifenesin |
| 09/06/2011 | US8012503 Administering propranolol or a derivative across a mucosal membrane in combination with a buffering agent (phosphate buffer) to provide a pH of 7.6 at the membrane; sublingual; cardiovascular disorders |
| 09/06/2011 | US8012499 Anthranilamides for controlling invertebrate pests |
| 09/06/2011 | US8012498 Topical gel formulation comprising organophosphate insecticide and preparation thereof |
| 09/06/2011 | US8012496 Gastric retention controlled drug delivery system |
| 09/06/2011 | US8012494 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/06/2011 | US8012486 Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient |
| 09/06/2011 | US8012463 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 09/06/2011 | US8012460 Mixture of hydroxyethyl cellulose, xanthan gum and carbopol" |
| 09/06/2011 | US8012454 Embolization |
| 09/06/2011 | CA2701704C Process for producing crystal |
| 09/06/2011 | CA2684105C Pyridine derivatives |
| 09/06/2011 | CA2670422C Spiroketone acetyl-coa carboxylase inhibitors |
| 09/06/2011 | CA2667041C N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression |
| 09/06/2011 | CA2656875C Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 09/06/2011 | CA2656181C Compressed preparation of compositions comprising olmesartan medoxomil |
| 09/06/2011 | CA2573510C Insulin secretion by anthocyanins and anthocyanidins |
| 09/06/2011 | CA2529347C Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
| 09/06/2011 | CA2519946C Temporary embolization using inverse thermosensitive polymers |
| 09/06/2011 | CA2502293C Ship 1 modulators |
| 09/06/2011 | CA2495454C Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2493536C 8-hydroxy quinoline derivatives |
| 09/06/2011 | CA2492130C Inhibitors of cyclin-dependent kinases and their use |
| 09/06/2011 | CA2488642C Aryl carbonyl derivatives as glucokinase activators |
| 09/06/2011 | CA2480552C Amidoacetonitrile compounds and their use as pesticides |
| 09/06/2011 | CA2469275C 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 09/06/2011 | CA2466965C Sulphonamide derivatives, their preparation and use as medicaments |
| 09/06/2011 | CA2465746C Hydrazono-malonitriles |
| 09/06/2011 | CA2457983C Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
| 09/06/2011 | CA2449419C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 09/06/2011 | CA2446074C Carbonic anhydrase activators for enhancing learning and memory |
| 09/06/2011 | CA2439410C Analogs of thalidomide as potential angiogenesis inhibitors |
| 09/06/2011 | CA2415228C Treatment of bone diseases |
| 09/06/2011 | CA2411882C Solid valsartan pharmaceutical compositions |
| 09/06/2011 | CA2410025C Use of biguanide derivatives for making a medicine having a wound healing effect |
| 09/06/2011 | CA2402774C Microsphere hydrogel biomedical articles |
| 09/06/2011 | CA2396148C Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/06/2011 | CA2336361C Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 09/05/2011 | CA2733374A1 Novel methods for treating wounds and skin irritations |
| 09/02/2011 | WO2010097344A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2784516A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2732915A1 Composition for down-regulating pro-inflammatory markers |
| 09/01/2011 | WO2011106729A2 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 09/01/2011 | WO2011106721A1 Flurbiprofen analogs and methods of use in treating cancer |
| 09/01/2011 | WO2011106702A2 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | WO2011106692A2 Methods of using (1s, 3s) -3-amino-4-difluoromethylenyl-1-cyclopentanoic acid |
| 09/01/2011 | WO2011106691A2 Curcumin derivatives |
| 09/01/2011 | WO2011106688A1 Bis-fatty acid conjugates and their uses |
| 09/01/2011 | WO2011106655A1 Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation |
| 09/01/2011 | WO2011106650A2 Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
| 09/01/2011 | WO2011106632A1 Substituted hydroxamic acids and uses thereof |
| 09/01/2011 | WO2011106599A1 Method of accelerating corneal wound healing |
| 09/01/2011 | WO2011106577A2 Method for treating brain cancer |
| 09/01/2011 | WO2011106573A2 Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| 09/01/2011 | WO2011106570A1 Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds |
| 09/01/2011 | WO2011106548A1 Amine polymers for use as bile acid sequestrants |
| 09/01/2011 | WO2011106545A1 Polyimidazoles for use as bile acid sequestrants |
| 09/01/2011 | WO2011106482A1 Formulations and methods for nutrient delivery |
| 09/01/2011 | WO2011106445A1 Antiviral compounds |
| 09/01/2011 | WO2011106416A2 Abuse-resistant formulations |
| 09/01/2011 | WO2011106414A1 Inhibitors of beta-secretase |
| 09/01/2011 | WO2011106408A1 The use of cinnabarinic acid as a modulator of immune response in autoimmune disorders |
| 09/01/2011 | WO2011106378A2 Oral b12 therapy |
| 09/01/2011 | WO2011106340A1 Pyrazolopyridazine derivatives for the treatment of hepatitis c |
| 09/01/2011 | WO2011106334A1 Treatment of dermatological allergic conditions |
| 09/01/2011 | WO2011106317A1 Estrogen receptor ligands and methods of use thereof |
| 09/01/2011 | WO2011106298A1 Braf mutations conferring resistance to braf inhibitors |
| 09/01/2011 | WO2011106276A1 Task channel antagonists |
| 09/01/2011 | WO2011106273A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 09/01/2011 | WO2011106248A2 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 09/01/2011 | WO2011106226A2 Prolylhydroxylase inhibitors and methods of use |
| 09/01/2011 | WO2011106168A1 Purine compounds for treating autoimmune and demyelinating diseases |
| 09/01/2011 | WO2011106114A1 Identification of human t2r receptors and the use thereof to identify inhibitors (blockers) of bitter taste |
| 09/01/2011 | WO2011106106A2 Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| 09/01/2011 | WO2011106003A1 Synthesis of magnolol and its analogue compounds |